Open access
Sep 2026
Tumor-derived MG53 aggravates gastrointestinal cancer cachexia related muscle atrophy by inhibiting the TLR4/PI3K/AKT/FOXO3a signaling pathway
MG53 correlates with muscle atrophy, supporting its potential as a diagnostic biomarker and therapeutic target of gastrointestinal cancer cachexia and its potential as a diagnostic biomarker and therapeutic target of cancer cachexia.
Yong-Fei Wang, Yuan-Yuan Xin, Si-Yuan Wang et al.
· Frontiers in Oncology · 0 citations